论文部分内容阅读
应用国产舒氨西林与氨苄西林随机对照治疗血液病合并感染患者４８例，结果舒氨西林临床有效率８３．４％，明显优于氨苄西林５０．０％（Ｐ＜０．０５），不良反应轻微。
48 cases of patients with blood-borne infections were treated by randomized controlled trials of domestic and imported ampicillin. The clinical efficacy of sulpacillin was 83.4%, which was significantly better than that of ampicillin 50.0% (P <0.05). Adverse reactions slight.